Litigation Details for Altaire Pharmaceuticals, Inc. v. Paragon BioTeck, Inc. (E.D.N.Y 2015)
✉ Email this page to a colleague
Altaire Pharmaceuticals, Inc. v. Paragon BioTeck, Inc. (E.D.N.Y 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-04-28 |
| Court | District Court, E.D. New York | Date Terminated | |
| Cause | 28:1332 Diversity-Breach of Contract | Assigned To | Leonard D. Wexler |
| Jury Demand | Plaintiff | Referred To | Magistrate Judge Anne Y. Shiel |
| Patents | 8,859,623 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Altaire Pharmaceuticals, Inc. v. Paragon BioTeck, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Altaire Pharmaceuticals, Inc. v. Paragon BioTeck, Inc. (E.D.N.Y 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-04-28 | 1 | subsequently issued a United States Patent No. 8,859,623 (the “’623 patent”), entitled “Methods and Compositions… the United States Patent and Trademark Office (“USPTO”) to obtain the ‘623 Patent. 23. …in its patent application and subsequent patent. 29. As a result…Agreement. Paragon’s Patent Application and Issuance 19. On…in connection with applying for and obtaining a patent for phenylephrine. 20. Altaire | External link to document | |
| 2015-08-14 | 22 | BioTeck, Inc.. (Attachments: # 1 Exhibit 1 Patent 8,859,623, # 2 Proposed Summons) (Klausner, Tonia) ( | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
